Last reviewed · How we verify

0.1% triamcinolone , 0.05% clobetasol propionate ointment

Mahidol University · FDA-approved active Small molecule Quality 1/100

0.1% triamcinolone , 0.05% clobetasol propionate ointment is a Small molecule drug developed by Mahidol University. It is currently FDA-approved. Also known as: Dermovate ointment.

At a glance

Generic name0.1% triamcinolone , 0.05% clobetasol propionate ointment
Also known asDermovate ointment
SponsorMahidol University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 0.1% triamcinolone , 0.05% clobetasol propionate ointment

What is 0.1% triamcinolone , 0.05% clobetasol propionate ointment?

0.1% triamcinolone , 0.05% clobetasol propionate ointment is a Small molecule drug developed by Mahidol University.

Who makes 0.1% triamcinolone , 0.05% clobetasol propionate ointment?

0.1% triamcinolone , 0.05% clobetasol propionate ointment is developed and marketed by Mahidol University (see full Mahidol University pipeline at /company/mahidol-university).

Is 0.1% triamcinolone , 0.05% clobetasol propionate ointment also known as anything else?

0.1% triamcinolone , 0.05% clobetasol propionate ointment is also known as Dermovate ointment.

What development phase is 0.1% triamcinolone , 0.05% clobetasol propionate ointment in?

0.1% triamcinolone , 0.05% clobetasol propionate ointment is FDA-approved (marketed).

Related